Literature DB >> 31161298

Structural Insight into the Binding Mode of FXR and GPBAR1 Modulators.

Francesco Saverio Di Leva1, Daniele Di Marino2,3, Vittorio Limongelli4,5.   

Abstract

In this chapter we provide an exhaustive overview of the binding modes of bile acid (BA) and non-BA ligands to the nuclear farnesoid X receptor (FXR) and the G-protein bile acid receptor 1 (GPBAR1). These two receptors play a key role in many diseases related to lipid and glucose disorders, thus representing promising pharmacological targets. We pay particular attention to the chemical and structural features of the ligand-receptor interaction, providing guidelines to achieve ligands endowed with selective or dual activity towards the receptor and paving the way to future drug design studies.

Entities:  

Keywords:  Bile acids; FXR; GPBAR1; Homology modelling; Molecular docking; Molecular dynamics (MD); X-ray crystallography

Mesh:

Substances:

Year:  2019        PMID: 31161298     DOI: 10.1007/164_2019_234

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  3 in total

1.  GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis.

Authors:  Simona De Marino; Claudia Finamore; Michele Biagioli; Adriana Carino; Silvia Marchianò; Rosalinda Roselli; Cristina Di Giorgio; Martina Bordoni; Francesco Saverio Di Leva; Ettore Novellino; Chiara Cassiano; Vittorio Limongelli; Angela Zampella; Carmen Festa; Stefano Fiorucci
Journal:  ACS Med Chem Lett       Date:  2020-03-02       Impact factor: 4.345

2.  Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease.

Authors:  Stefano Fiorucci; Pasquale Rapacciuolo; Bianca Fiorillo; Rosalinda Roselli; Silvia Marchianò; Cristina Di Giorgio; Martina Bordoni; Rachele Bellini; Chiara Cassiano; Paolo Conflitti; Bruno Catalanotti; Vittorio Limongelli; Valentina Sepe; Michele Biagioli; Angela Zampella
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 3.  Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists.

Authors:  Ludovico Abenavoli; Anna Caterina Procopio; Sharmila Fagoonee; Rinaldo Pellicano; Marco Carbone; Francesco Luzza; Pietro Invernizzi
Journal:  Diseases       Date:  2020-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.